Cambridge, MA, August 10, 2008 --(PR.com
)-- The industry momentum on developing sequencing technologies have reached an all time high, creating new opportunities for diagnostics and personalized medicine. Harry Glorikian, Management Consultant and Managing Partner of Scientia Advisors, an international management strategy consulting firm concentrating in biotechnology and life sciences will be performing a strategic review of molecular diagnostics at the TriMark conference, October 6th 2008 held at the Princeton Club of New York, NY. For more information visit http://www.trimarkpublications.com/conferences/mdc2008/agenda.htm
Harry Glorikian’s experience allows him to intellectually address a broad range of areas within life sciences. His direct experience in sales, marketing, business development, and intellectual property combined with his technical and market knowledge provides both a unique and insightful perspective. Harry has more than 15 years of experience in the life science industry, developing and executing key strategic acquisitions and licensing arrangements which target revenue growth. Harry currently leads Scientia, which includes the management of consulting teams, new business development, and intellectual capital development. His client engagements have involved comprehensive go-to-market plans in the areas of diagnostics, genomic, proteomics, cell biology, cellular therapy and consumables & services groups. Scientia’s clients range from emerging innovators to global market leaders.